Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AemetisAMTX +3.39%48 Days Sales Outstanding is 6.48 as of Jun. 2026, which is 85% above its 10-year median of 3.50. GuruFocus rates AMTX with a GF Score™ of 48/100 and a GF Value™ of $1.94 (Fairly Valued). The stock has 6 warning signs investors should review. Among 1,585 Chemicals companies, Aemetis ranks better than 98.23% on this metric.
Aemetis's average Accounts Receivable for the
three
months ended in Jun. 2026 was $4.4 Mil. Aemetis's Revenue for the
three
months ended in Jun. 2026 was $62.7 Mil.
Hence, Aemetis's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 6.48.
The historical rank and industry rank for Aemetis's Days Sales Outstanding or its related term are showing as below:
AMTX'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 2.01 Med: 3.5 Max: 9.67
Current: 4.35
During the past 13 years, Aemetis's highest Days Sales Outstanding was 9.67. The lowest was 2.01. And the median was 3.50.
AMTX's Days Sales Outstanding is ranked better than 98.23% of 1585
companies
in the Chemicals industry
Industry Median: 63.28
vs AMTX: 4.35
Aemetis's Days Sales Outstanding
increased
from Jun. 2025 (3.27) to Jun. 2026 (6.48).
Aemetis (NAS:AMTX) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Aemetis Days Sales Outstanding Related Terms
Aemetis Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Aemetis's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AMTX vs KBLB, NTIC, FSI: Days Sales Outstanding Comparison
For the Specialty Chemicals subindustry, Aemetis's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aemetis Days Sales Outstanding vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Aemetis's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Aemetis's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aemetis (AMTX) has a Days Sales Outstanding of 6.48 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Aemetis and its competitors. This is 85% above median its historical median of 3.50. Over the past decade, Aemetis' Days Sales Outstanding has ranged from 2.01 to 9.67. According to the industry distribution chart, Aemetis ranks #28 out of 1585 companies in the Chemicals industry, placing it in the top 1.8%.
Is Aemetis' Days Sales Outstanding too high?
Aemetis' current Days Sales Outstanding of 6.48 is 85% above median its 10-year median of 3.50. Over the past 10 years, this metric has ranged from a low of 2.01 to a high of 9.67. The Chemicals industry median Days Sales Outstanding is 63.28. Aemetis' value of 6.48 is 89.8% below this industry median. Based on the distribution chart, Aemetis ranks #28 out of 1585 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Aemetis has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aemetis' Days Sales Outstanding compare to KBLB and NTIC?
According to the Chemicals industry distribution chart, Aemetis ranks #28 out of 1585 companies for Days Sales Outstanding. This places Aemetis in the top 2% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 63.28. Aemetis' value of 6.48 is 89.8% below this benchmark. Historically, Aemetis' own Days Sales Outstanding has ranged from 2.01 to 9.67 over the past decade. While the company's 10-year median is 3.50 vs. the industry median of 63.28, Aemetis has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Chemicals company?
The median Days Sales Outstanding among Chemicals companies is 63.28, based on 1,585 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aemetis's current Days Sales Outstanding of 6.48 is 89.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Aemetis and its competitors. For the Chemicals industry, the median Days Sales Outstanding is 63.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aemetis's current Days Sales Outstanding is 6.48, which is 85% above median its own 10-year median of 3.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aemetis stock overvalued right now?
Based on GuruFocus' analysis, Aemetis (AMTX) is currently considered Fairly Valued. The stock's GF Value™ is $1.94, compared to a current price of $1.83 — trading 5.7% below its estimated fair value. The current Days Sales Outstanding is 6.48, which is 85% above median its 10-year median of 3.50 and 89.8% below the Chemicals industry median of 63.28. Aemetis' overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Aemetis (AMTX), the current Days Sales Outstanding is 6.48 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aemetis (AMTX) Overvalued in 2026?
Based on GuruFocus' analysis, Aemetis stock appears to be undervalued.
The current stock price of $1.83 is trading 5.7% below its estimated GF Value™ of $1.94.
GuruFocus considers Aemetis to be Fairly Valued.
Key valuation signals for AMTX:
Days Sales Outstanding: 6.48 (85% above median its 10-year median of 3.50)
GF Value™: $1.94 vs. price of $1.83 (5.7% below fair value)
Industry Position: 89.8% below the Chemicals median (#28 of 1585)
No single metric tells the full story. See the AMTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. The operations include California Ethanol, California Dairy Renewable Natural Gas and India Biodiesel. It operates in the reportable geographic segments of North America and India.
48GF Score
Get the complete analysis for AMTX
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMTX has been successfully added to your 
